Login to Your Account

FDA Approves First New Therapy for DME in 25 Years

By Catherine Shaffer
Staff Writer

Monday, August 13, 2012

The FDA approved Lucentis (ranibizumab injection) for diabetic macular edema (DME), offering patients the first improvement on the standard-of-care in 25 years.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription